Regen BioPharma Inc Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Regen BioPharma Inc annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2013 to Q4 2023.
  • Regen BioPharma Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $166K.
  • Regen BioPharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $573K, a 135% increase from 2023.
  • Regen BioPharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $244K.
  • Regen BioPharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$94K, a 107% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $166K +$166K Oct 1, 2023 Dec 31, 2023 10-Q 2024-01-19
Q4 2022 $0 +$94.5K Oct 1, 2022 Dec 31, 2022 10-Q 2023-01-19
Q4 2021 -$94.5K -$94.5K Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-19
Q4 2020 $0 +$31.8K Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-20
Q4 2019 -$31.8K -$163K -124% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-13
Q4 2018 $131K -$488K -78.8% Oct 1, 2018 Dec 31, 2018 10-Q 2021-08-05
Q4 2017 $619K -$81.2K -11.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-12
Q4 2016 $700K +$145K +26.1% Oct 1, 2016 Dec 31, 2016 10-Q 2017-01-27
Q4 2015 $555K +$305K +121% Oct 1, 2015 Dec 31, 2015 10-Q 2017-01-27
Q4 2014 $251K -$94.3K -27.3% Oct 1, 2014 Dec 31, 2014 10-Q/A 2017-04-28
Q4 2013 $345K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.